搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Silicibacter sp. 50S ribosomal protein L7/L12 (rplL) CSB-YP624822SAAR
CSB-EP624822SAAR
CSB-BP624822SAAR
CSB-MP624822SAAR
CSB-EP624822SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Peptidyl-tRNA hydrolase (pth) CSB-YP624823SAAR
CSB-EP624823SAAR
CSB-BP624823SAAR
CSB-MP624823SAAR
CSB-EP624823SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Probable rRNA maturation factor (TM1040_0190) CSB-YP624824SAAR
CSB-EP624824SAAR
CSB-BP624824SAAR
CSB-MP624824SAAR
CSB-EP624824SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. UPF0434 protein TM1040_0056 (TM1040_0056) CSB-YP624825SAAR
CSB-EP624825SAAR
CSB-BP624825SAAR
CSB-MP624825SAAR
CSB-EP624825SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Phosphonates import ATP-binding protein PhnC 2 (phnC2) CSB-YP624826SAAR
CSB-EP624826SAAR
CSB-BP624826SAAR
CSB-MP624826SAAR
CSB-EP624826SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Probable chemoreceptor glutamine deamidase CheD 1 (cheD1) CSB-YP624827SAAR
CSB-EP624827SAAR
CSB-BP624827SAAR
CSB-MP624827SAAR
CSB-EP624827SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Guanylate kinase (gmk) CSB-YP624828SAAS
CSB-EP624828SAAS
CSB-BP624828SAAS
CSB-MP624828SAAS
CSB-EP624828SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis S-adenosylmethionine synthase (metK) CSB-YP624829SAAS
CSB-EP624829SAAS
CSB-BP624829SAAS
CSB-MP624829SAAS
CSB-EP624829SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Pantothenate synthetase (panC) CSB-YP624830SAAS
CSB-EP624830SAAS
CSB-BP624830SAAS
CSB-MP624830SAAS
CSB-EP624830SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L35 (rpmI) CSB-YP624831SAAS
CSB-EP624831SAAS
CSB-BP624831SAAS
CSB-MP624831SAAS
CSB-EP624831SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP624832SAAS
CSB-EP624832SAAS
CSB-BP624832SAAS
CSB-MP624832SAAS
CSB-EP624832SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 30S ribosomal protein S7 (rpsG) CSB-YP624833SAAS
CSB-EP624833SAAS
CSB-BP624833SAAS
CSB-MP624833SAAS
CSB-EP624833SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L22 (rplV) CSB-YP624834SAAS
CSB-EP624834SAAS
CSB-BP624834SAAS
CSB-MP624834SAAS
CSB-EP624834SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L14 (rplN) CSB-YP624835SAAS
CSB-EP624835SAAS
CSB-BP624835SAAS
CSB-MP624835SAAS
CSB-EP624835SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Adenylate kinase (adk) CSB-YP624836SAAS
CSB-EP624836SAAS
CSB-BP624836SAAS
CSB-MP624836SAAS
CSB-EP624836SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis tRNA (guanine-N (1)-)-methyltransferase (trmD) CSB-YP624837SAAS
CSB-EP624837SAAS
CSB-BP624837SAAS
CSB-MP624837SAAS
CSB-EP624837SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 1-deoxy-D-xylulose-5-phosphate synthase (dxs), partial CSB-YP624838SAAS
CSB-EP624838SAAS
CSB-BP624838SAAS
CSB-MP624838SAAS
CSB-EP624838SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP624839SAAS
CSB-EP624839SAAS
CSB-BP624839SAAS
CSB-MP624839SAAS
CSB-EP624839SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Elongation factor 4 (lepA), partial CSB-YP624840SAAS
CSB-EP624840SAAS
CSB-BP624840SAAS
CSB-MP624840SAAS
CSB-EP624840SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP624841SAAS
CSB-EP624841SAAS
CSB-BP624841SAAS
CSB-MP624841SAAS
CSB-EP624841SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>